Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban
28 August 2016 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
22 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
14:00 CET
You may be interested in
Congress Presentation
